Tripathi, V., Shin, J., Stuelten, C. H., & Zhang, Y. E. (2019). TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance. Oncogene.
Chicago Style CitationTripathi, Veenu, Jee-Hye Shin, Christina H. Stuelten, i Ying E. Zhang. "TGF-β-induced Alternative Splicing of TAK1 Promotes EMT and Drug Resistance." Oncogene 2019.
Cita MLATripathi, Veenu, Jee-Hye Shin, Christina H. Stuelten, i Ying E. Zhang. "TGF-β-induced Alternative Splicing of TAK1 Promotes EMT and Drug Resistance." Oncogene 2019.
Atenció: Aquestes cites poden no estar 100% correctes.